Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
about
Polycystic ovary syndrome in women using valproate: a review.High-fat diet-induced obesity exacerbates kainic acid-induced hippocampal cell death.Valproate treatment and cocaine cue reactivity in cocaine dependent individuals.Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy.Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.Weight change, genetics and antiepileptic drugs.Antiepileptic drugs influences on body weight in people with epilepsy.Valproic acid and nonalcoholic fatty liver disease: A possible association?Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?Serum Insulin and Leptin Levels in Children with Epilepsy on Valproate-associated Obesity.Weight gain and insulin resistance in children treated with valproate: the influence of time.Effect of antiepilepsy drug therapy on ventricular function in children with epilepsy: a tissue Doppler imaging study.Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.Insulin resistance in patients on valproic acid: relation to adiponectin.Fatty liver in adults receiving antiepileptic medications: relationship to the metabolic risks.Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.Leptin: role over central nervous system in epilepsy
P2860
Q34881401-A84281CC-68CD-4136-99FD-09EA2F9246D9Q35827711-7F015FEF-2CC1-4A3E-89E8-1F7D49C9173CQ37267352-CCD34F4B-80D2-42AB-9369-841CF0831500Q37324686-39EA1F65-E138-42C7-B368-F860D09EBF2EQ37794213-120B72A3-EB3A-4D0F-A17A-26DB2ABBF48BQ38168942-98F47ADE-BFC6-4CE7-A6F3-D59F25B47B66Q38285318-CEE3F9C8-F68E-4D52-826C-4594E958F012Q38505408-341F7D1E-EC3B-4C8D-A228-A4C5E49EDCD9Q41049740-44B8236A-6ACF-420E-92F5-AC1466B16543Q41593966-5BBC9E16-BC37-40B2-8234-D68731B6A373Q43140659-1A63E204-3988-4C74-8A10-651A75F1712BQ43905937-4C941437-ED5C-4A26-98CD-F002B3E2ECF3Q46208501-08E2221D-410F-48E8-9432-42541EEAB909Q46601959-182CDFBD-B2A4-4D4D-BA46-17C3D044E217Q46784965-F5C64ADF-22E1-4DC5-97B8-4AF49185F661Q51356301-5BB6E315-D469-45DB-AD80-BEA130023129Q57970623-090CCF3C-F48D-4E30-8591-77CC3F7FC2BB
P2860
Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@en
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@nl
type
label
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@en
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@nl
prefLabel
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@en
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@nl
P2093
P2860
P1476
Serum insulin, leptin, and neu ...... ildren treated with valproate.
@en
P2093
Ayse Serdaroglu
Aysun Bideci
Cetin Okuyaz
Kivilcim Gucuyener
Kursad Aydin
P2860
P304
P356
10.1177/08830738050200101501
P577
2005-10-01T00:00:00Z